Overview
N-acetyltyrosine, also referred to as N-acetyl-L-tyrosine, is used in place of as a tyrosine precursor. Tyrosine is a non-essential amino acid with a polar side group. N-acetyltyrosine is administered as parenteral nutrition or intravenous infusion due to its enhanced solubility compared to tyrosine . It is typically administered as a source of nutritional support where oral nutrition is inadequate or cannot be tolerated.
Indication
N-acetyltyrosine is indicated, in combination with several other amino acids and dextrose, as a peripherally administered source of nitrogen for nutritional support in patients with adequate stores of body fat in whom, for short periods, oral administration cannot be tolerated, is undesirable, or inadequate . It is also indicated, with other amino acids, 5-10% dextrose, and fat emulsion, for parenteral nutrition to preserve protein and reduce catabolism in stress conditions where oral administration is inadequate . When administered with other amino acids and concentrated dextrose, it is indicated for central vein infusion to prevent or reverse negative nitrogen balance in patients where the alimentary tract by the oral, gastrostomy, or jejestomy routes cannot or should not be used or in patients in which gastrointestinal absorption of protein is impaired, metabolic requirements for protein are substantially increased, or morbidity and mortality may be reduced by replacing amino acids lost from tissue breakdown
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
---|---|---|---|---|---|
No FDA approvals found for this drug. |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
---|---|---|---|
No EMA approvals found for this drug. |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No HSA approvals found for this drug. |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
---|---|---|---|---|---|
No NMPA approvals found for this drug. |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
---|---|---|---|---|---|
No PPB approvals found for this drug. |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
---|---|---|---|---|---|
No TGA approvals found for this drug. |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
---|---|---|---|---|---|
AMINOSYN II 8.5% WITH 50% DEXTROSE | hospira healthcare ulc | 00742767 | Solution - Intravenous | 115 MG / 100 ML | 12/31/1988 |
AMINOSYN II 7% WITH 10% DEXTROSE | hospira healthcare ulc | 00742740 | Solution - Intravenous | 94 MG / 100 ML | 12/31/1988 |
AMINOSYN II IN DEXTROSE INJECTION | hospira healthcare ulc | 00839302 | Solution - Intravenous | 115 MG / 100 ML | 12/31/1991 |
AMINOSYN II 8.5% INJECTION | hospira healthcare ulc | 00742627 | Solution - Intravenous | 230 MG / 100 ML | 12/31/1987 |
AMINOSYN II 7% INJECTION | hospira healthcare ulc | 00742635 | Solution - Intravenous | 189 MG / 100 ML | 12/31/1987 |
AMINOSYN II IN DEXTROSE INJECTION | hospira healthcare ulc | 00742783 | Solution - Intravenous | 135 MG / 100 ML | 12/31/1987 |
AMINOSYN II 5% INJ | ABBOTT LABORATORIES, LIMITED | 00742643 | Liquid - Intravenous | 135 MG / 100 ML | 12/31/1988 |
AMINOSYN II | ICU Medical Canada Inc | 02126745 | Solution - Intravenous | 405 MG / 100 ML | 12/31/1995 |
AMINOSYN II 8.5% M IN 20% DEXTROSE (DUAL CHAMBER) | hospira healthcare ulc | 00742716 | Solution - Intravenous | 115 MG / 100 ML | 12/31/1987 |
AMINOSYN II 10% WITH ELECTROLYTES | hospira healthcare ulc | 00742651 | Solution - Intravenous | 270 MG / 100 ML | 12/31/1991 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
---|---|---|---|---|---|
No CIMA AEMPS (Spain) approvals found for this drug. |
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Philippines FDA approvals found for this drug. |
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Saudi SFDA approvals found for this drug. |
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Malaysia NPRA approvals found for this drug. |
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
---|---|---|---|---|---|
No UK EMC drug information found for this drug. |
Help Us Improve
Your feedback helps us provide better drug information and insights.